Transition Therapeutics Inc.
Profile
Mailing Address: Transition Therapeutics Inc.
101 College Street
Suite 220
Toronto, ON
M5G 1L7
Head Office Address: 101 College Street
Suite 220
Toronto, ON
M5G 1L7
Contact Name: Nicole Rusaw Principal Regulator: Ontario
Business e-mail address: nrusaw@transitiontherapeutics.com Short Form Prospectus Issuer: Yes
Telephone Number: 416 260-7770 Reporting Jurisdictions: Ceased Reporting
Fax Number: 416 260-2886 Stock Exchange: TSX, NASDAQ
Date of Formation: Jul 6 1998 Stock Symbol:
Jurisdiction Where Formed: Ontario Auditor: PricewaterhouseCoopers LLP
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 893716 Transfer Agent: Computershare Investor Services Inc.
Financial Year-End: Jun 30 Size of Issuer (Assets): $25,000,001 to $100,000,000


View This Company's Documents